[1]
Suryani, Y. et al. 2019. Immunoinformatics Study on Early 4 Protein of Human Papillomavirus Type 16 for Cervical Cancer Vaccine Peptide Candidate. Jurnal Biodjati. 4, 2 (Nov. 2019), 252–262. DOI:https://doi.org/10.15575/biodjati.v4i2.5414.